ANTI-PD-1 ANTIBODY-ATTENUATED IL-2 IMMUNOCONJUGATE FORMULATIONS
Application
US20260083857A1
Kind: A1
Mar 26, 2026
Inventors
Haichen Nie, Pragya Manandhar, Zaneta Maijorovaite, Wei Liu
Abstract
Disclosed herein are stable pharmaceutical formulations comprising anti-human PD-1 (hPD-1) antibody-modified human interleukin-2 (hIL-2) immunoconjugates and uses thereof.
CPC Classifications
A61K 47/6851
A61K 47/12
A61K 47/183
A61K 47/26
A61K 47/6813
C07K 14/55
C07K 16/2818
C07K 2317/92
Filing Date
2025-09-22
Application No.
19335771